Fortis Healthcare · NSE: FORTIS · BSE: 532843

Q1 FY22 results · Apr–Jun 2021

Fortis Healthcare reported revenue from operations of ₹1,410.31 crore (up 132.7% from Q1 FY21) and net profit of ₹430.61 crore for Q1 FY22 (Apr–Jun 2021), on a consolidated basis.

Consolidated · ₹ crore
Item	Q1 FY22	Q1 FY21	YoY	Q4 FY21	QoQ
Revenue from operations	1,410.31	605.95	+132.7%	1,252.44	+12.6%
Other income	7.84	4.45	+76.2%	6.34	+23.7%
Total income	1,418.15	610.40	+132.3%	1,258.78	+12.7%
Profit before share of associates & JVs and tax	477.89	(211.12)	Turned profit	91.64	+421.5%
Share of profit/(loss) of associates & JVs	8.50	2.86		18.73
Net profit for the period	430.61	(187.88)	Turned profit	62.36	+590.5%
Attributable to shareholders of the company	263.55	(178.92)	Turned profit	43.17	+510.5%
EPS, basic (₹)	3.49	(2.37)	Turned profit	0.57	+512.3%
Net margin (%)	30.5	-31.0		5.0

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q1 FY22	Q1 FY21	YoY	Q4 FY21	QoQ
Revenue from operations	203.52	100.56	+102.4%	194.82	+4.5%
Other income	33.49	53.55	−37.5%	27.38	+22.3%
Total income	237.01	154.11	+53.8%	222.20	+6.7%
Profit before tax	(2.34)	31.10	Turned loss	(45.09)	Loss narrowed
Net profit for the period	(1.73)	19.90	Turned loss	(41.10)	Loss narrowed
EPS, basic (₹)	(0.02)	0.26	Turned loss	(0.54)	Loss narrowed
Net margin (%)	-0.9	19.8		-21.1

Consolidated

Filed with BSE: 13 Aug 2021, 18:44 IST
Board meeting: 13 Aug 2021
Period: 01 Apr 2021 to 30 Jun 2021
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 13 Aug 2021, 18:44 IST
Board meeting: 13 Aug 2021
Period: 01 Apr 2021 to 30 Jun 2021
Review status: Unaudited
Source: XBRL filing on BSE